FDA Modernization Act 3.0
Key claim: HR2821 (FDA Modernization Act 3.0) was placed on the Union Calendar in the 119th Congress as of June 2026, advancing the bill toward House floor consideration.
Abstract
(HR2821 · 119th Congress) Latest action (2026-06-18): Placed on the Union Calendar, Calendar No. 614.
Why this matters
The FDA Modernization Act 3.0 would expand the legal footing for non-animal testing methods in FDA drug review, potentially affecting how quickly and cheaply new therapies reach patients and how sponsors design preclinical programs. Union Calendar placement is a procedural milestone that makes House floor action possible, though not guaranteed. For patients, providers, and manufacturers, the practical impact hinges on final enactment and downstream FDA implementation guidance.